Cannabis Breeding Enters Its Next Era
Cannabis breeding techniques are evolving to create more consistent cannabinoid and terpene profiles. These advances could improve dosing predictability and therapeutic outcomes. Cannabis breeding techniques represent a shift toward pharmaceutical-like…
Cannabis Testing Challenges Persist as Virginia Retail Market Nears
Laboratory testing inconsistencies cannabis create challenges for patient safety and dosing accuracy in medical cannabis programs. Virginia's retail market faces these issues as testing variability affects product reliability. Patients and clinicians…
Understanding Rising THC Concentrations and Patient Safety
Rising THC concentrations in cannabis products significantly affect dosing precision and patient safety. Clinicians must understand these changes to optimize therapeutic outcomes. This article discusses the implications of rising THC concentrations for…
Increased Amount of Medical Cannabis Used Per Week is Associated with Less Memory Dysfunction
New research on medical cannabis cognitive function reveals that higher weekly usage is linked to less memory dysfunction. This challenges common assumptions about cannabis and cognitive impairment. Understanding therapeutic dosing is key to optimizing…
A Prescription Digital Therapeutic Framework for Enhancing Medical Cannabis Care
Digital therapeutics cannabinoid medicine offers new tools for precise symptom tracking and treatment adjustment in medical cannabis care. This framework supports individualized dosing and accountable therapeutic protocols. It helps close evidence gaps…
Nebraska’s Medical Cannabis Commission Holds Hearing on Emergency Regulations
Nebraska medical cannabis emergency regulations propose a strict 5-gram THC possession cap that may limit effective symptom management. Patients with serious conditions often require higher doses for relief, making these limits clinically concerning. The…
Cannabis Use Associated with Worse Working Memory – EMJ
Heavy cannabis use working memory effects are linked to reduced brain activation during memory tasks. Dose, frequency, and cannabinoid profile influence cognitive outcomes. Medical patients using low-to-moderate doses face a different risk profile.